Text Size
Trial record 10 of 27 for:    Open Studies | "Lenses, Intraocular"
Previous Study | Return to List | Next Study

Intraocular Lens (IOL) Calculation Improvement

This study is currently recruiting participants.
Verified June 2011 by University Hospital, Basel, Switzerland
Sponsor:
Information provided by:
University Hospital, Basel, Switzerland
ClinicalTrials.gov Identifier:
NCT01372657
First received: June 7, 2011
Last updated: June 13, 2011
Last verified: June 2011
History of Changes
  Purpose

Intraocular Lens (IOL) formulas sometimes differ from expected. Using novel measurement methods before and after cataract surgery improved formulas are tried be developed.


Condition Intervention
Cataract
 Other: biometry calculation

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Intraocular Lens (IOL) Formula Calculation Improvement

Resource links provided by NLM:

MedlinePlus related topics: Cataract
U.S. FDA Resources

Further study details as provided by University Hospital, Basel, Switzerland:

Primary Outcome Measures:
  • postoperative refraction (Diopters) [ Time Frame: 2 years ] [ Designated as safety issue: No ]

Estimated Enrollment: 250
Study Start Date: April 2011
Estimated Primary Completion Date: May 2013 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
cataract patients Other: biometry calculation

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

cataract patients

Criteria

Inclusion Criteria:

  • older 18
  • clear cornea
  • cataract
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01372657

Contacts
Contact: David Goldblum, MD 41612652525 dgoldblum@uhbs.ch

Locations
Switzerland
Augenzentrum Bahnhof Basel Recruiting
Basel, Switzerland, 4051
Principal Investigator: Frank Sachers, MD            
Sponsors and Collaborators
University Hospital, Basel, Switzerland
Investigators
Study Director: David Goldblum, MD University Basel
  More Information

No publications provided

Responsible Party: David Goldblum, University Basel
ClinicalTrials.gov Identifier: NCT01372657     History of Changes
Other Study ID Numbers: EK 304/10
Study First Received: June 7, 2011
Last Updated: June 13, 2011
Health Authority: Switzerland: Ethikkommission

Keywords provided by University Hospital, Basel, Switzerland:
cataract
refraction
iol
calculation
formula

Additional relevant MeSH terms:
Cataract
Lens Diseases
Eye Diseases

ClinicalTrials.gov processed this record on May 23, 2013